Letter Sequence Other |
|---|
|
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017
Irrevocable Standby Letter of Credit (Redacted)
Project stage: Request
ML18054A0772018-03-0808 March 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18092A0872018-03-27027 March 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18087A3892018-03-28028 March 2018
Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC
Project stage: Request
ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018
Shine Medical Technologies, Inc. April 3, 2018 Public Meeting
Project stage: Request
ML18096A6882018-04-0303 April 2018
Confirmatory Action Letter (CAL) No. NRR-2011-001
Project stage: Request
ML18096A4552018-04-0303 April 2018
Shine Operating License Pre-Application Meeting (Environmental Presentation Slides)
Project stage: Meeting
ML18087A3402018-04-0303 April 2018
Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18096A6892018-04-0303 April 2018
Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations
Project stage: Request
ML18130A5782018-05-0707 May 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18162A1362018-05-11011 May 2018, 18 June 2018
Shine Medical Technologies, Inc. May 23, 2018 Public Meeting
Project stage: Request
ML18138A2912018-05-16016 May 2018
Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC
Project stage: Request
ML18128A0342018-05-16016 May 2018
Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18156A1302018-06-0101 June 2018
Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18155A6032018-06-0707 June 2018
Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18162A1172018-06-18018 June 2018
Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report
Project stage: Other
ML18162A0552018-06-18018 June 2018
Shine Medical Technologies April 3, 2018 Public Meeting Summary
Project stage: Meeting
ML18162A1162018-06-18018 June 2018
Shine Medical Technologies Annual Financial Report
Project stage: Request
ML18162A1182018-06-18018 June 2018
Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report
Project stage: Other
ML18162A1292018-06-18018 June 2018
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions
Project stage: Other
ML18162A1382018-06-18018 June 2018
May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc
Project stage: Meeting
ML18127B7062018-06-21021 June 2018
Closure of NRC Confirmatory Action Letter No. NRR-2011-001
Project stage: Other
ML18221A4532018-06-27027 June 2018, 17 August 2018
Shine Medical Technologies, Inc. June 2018 Public Meeting
Project stage: Request
ML18187A2162018-07-0202 July 2018
Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC
Project stage: Request
ML18197A0802018-07-10010 July 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18193A1412018-07-16016 July 2018
Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18277A1962018-07-17017 July 2018
Amendment to Standby Letter of Credit (Redacted)
Project stage: Request
ML18206A7262018-07-18018 July 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted)
Project stage: Request
ML18221A4542018-08-17017 August 2018
Summary of Meeting with Shine Medical Technologies, Inc
Project stage: Meeting
ML18221A4552018-08-17017 August 2018
Shine Medical Technologies, Inc. Request for Withholding Information from Public Disclosure of Proprietary Information
Project stage: Withholding Request Acceptance
ML18239A2192018-08-27027 August 2018
Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility
Project stage: Request
ML18268A3442018-10-0202 October 2018
Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014
Project stage: Other
ML18340A1712018-12-10010 December 2018
Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions
Project stage: Other
ML18340A2762018-12-19019 December 2018
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements
Project stage: Other
ML19025A2642019-01-22022 January 2019
Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC
Project stage: Request
ML19024A3522019-01-22022 January 2019
Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC
Project stage: Request
ML19025A2752019-01-22022 January 2019
Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC
Project stage: Request
ML19015A3522019-02-15015 February 2019
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML19071A1852019-03-22022 March 2019
Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure
Project stage: Other
ML19071A1812019-03-22022 March 2019
Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary
Project stage: Meeting
ML19071A1792019-03-22022 March 2019
Shine Medical Technologies, Inc. January 31, 2019 Public Meeting
Project stage: Request
ML19071A1802019-03-22022 March 2019
Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure
Project stage: Withholding Request Acceptance
2018-06-18
[Table View] |
Text
June 18, 2018 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, INC. - REQUEST FOR WITHHOLDING INFORMATION FROM PUBLIC DISCLOSURE (EPID NO. L-2017-PMP-0014)
Dear Dr. Piefer:
By letter dated May 11, 2017 (Agencywide Documents Access and Management System Accession No. ML17135A337), SHINE Medical Technologies, Inc. (SHINE) submitted an affidavit executed by James Costedio, which requested that information contained in the following document be withheld from public disclosure pursuant to the Title 10 of the Code of Federal Regulations (10 CFR), Section 2.390:
SHINE Medical Technologies, Inc. Financial Statements Years Ended December 31, 2016 and 2015 The affidavit stated that the submitted information should be considered exempt from mandatory public disclosure for the following reasons:
- a. The information sought to be withheld from public disclosure contained in of SMT 2017-017 is owned by SHINE, its affiliates, or third parties to whom SHINE has an obligation to maintain its confidentiality. This information is and has been held in confidence by SHINE.
- b. The information sought to be protected in Enclosure 1 is not available to the public to the best of my knowledge and belief.
- c. The information contained in Enclosure 1 is of the type that is customarily held in confidence by SHINE, and there is a rational basis for doing so. The information that SHINE is requesting to be withheld from public disclosure includes trade secret, commercial financial information, commercial information, or information that is subject to export controls. SHINE limits access to these elements to those with a need to know, and subject to maintaining confidentiality.
- d. Public disclosure of the information in Enclosure 1 would create substantial harm to SHINE because it would reveal valuable business information regarding SHINEs competitive expectations, assumptions, processes, and current position.
Its use by a competitor could substantially improve their competitive position in the design, manufacture, shipment, installation, assurance of quality, or licensing of a similar product.
The U.S. Nuclear Regulatory Commission (NRC) staff has reviewed your submittal in accordance with the requirements of 10 CFR 2.390 and, on the basis of the statements in the affidavit, has determined that the submitted information sought to be withheld contains proprietary commercial information and should be withheld from public disclosure.
Therefore, the submitted information marked as proprietary, will be withheld from public disclosure pursuant to 10 CFR 2.390(b)(5) and Section 103(b) of the Atomic Energy Act of 1954, as amended.
Withholding from public inspection shall not affect the right, if any, of persons properly and directly concerned to inspect the documents. If the need arises, we may send copies of this information to our consultants working in this area. We will, of course, ensure that the consultants have signed the appropriate agreements for handling proprietary information.
If the basis for withholding information from public inspection should change in the future such that the information could then be made available for public inspection, you should promptly notify the NRC. You also should understand that the NRC may have cause to review this determination in the future, for example, if the scope of a Freedom of Information Act request includes your information. In all review situations, if the NRC makes a determination adverse to the above, you will be notified in advance of any public disclosure.
If you have any questions regarding this matter, I may be reached at (301) 415-1524 or by electronic mail at Steven.Lynch@nrc.gov.
Sincerely,
/RA/
Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608
ML18162A118; Withholding Ltr.; ML18162A117, Ltr, ML18162A116, Pkg
- concurred via email OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA*
NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME SLynch NParker AAdams SLynch DATE 06/08/2018 6/13/18 6/15/18 6/18/18